Project Grant R43IP001282
Award Date 9/30/25
Completion Date 9/29/26
Dollars Obligated $279K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA, USA
Similar Awards
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $233,666 Project Grant to Esper Biosciences Inc. in Ithaca, NY on September 30, 2025 under the CDC Investigations and Technical Assistance program (CFDA 93.283). The grant funding supports the development of a rapid point-of-care nucleic acid test for Hepatitis C using nanosensors. This project aligns with the CDC program's goals of controlling communicable diseases and developing innovative health technologies. The award has...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $265,850 Project Grant to SKM Instruments, LLC on Sep 30, 2025 under the CDC Investigations and Technical Assistance program (CFDA 93.283). The grant supports the development of an ULTRA-RAPID OPTICAL PLATFORM FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING (AST) OF PULMONARY NON-TUBERCULOUS MYCOBACTERIAL (NTM) INFECTIONS. The project aims to create an innovative health technology to enhance disease detection and prevention...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1,047,807 Project Grant under the CDC Investigations and Technical Assistance program (CFDA 93.283) to Nanohmics Inc., a small technology development company based in Austin, TX. The grant, with a performance period from September 30, 2025 to September 29, 2027, supports the development of Lateral Flow-Electrochemiluminescent (LF-ECL) test strips and a portable reader system for ultrasensitive detection of foodborne...
- The Centers for Disease Control and Prevention (CDC) awarded a $300,000 Project Grant to Pace Diagnostics, Inc. under the CDC Investigations and Technical Assistance program (CFDA 93.283). The funding will support the development of an ultrasensitive urine tuberculosis (TB) antigen rapid detection test for the diagnosis of active TB. The project period is from Sep 30, 2025 to Mar 31, 2026. The CDC Investigations and Technical Assistance program funds research, surveillance, epidemiological...
- This $994,658 Project Grant was awarded on September 30, 2025 by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283) to Lo Biosciences, Inc., a minority-owned biotechnology company based in Rockville, Maryland. The award supports the development of a novel remote blood separation device for at-home plasma collection to enable HIV-1 testing. This project aims to create an innovative diagnostic technology that improves the...
- This $288,023 federal Project Grant was awarded by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283). The grant was awarded on July 1, 2025 to the University of Vermont & State Agricultural College to study the feasibility and acceptability of tele-exercise to improve physical function in World Trade Center responders with prostate cancer. The funding will support research, surveillance, and technical assistance...
- The Centers for Disease Control and Prevention (CDC) awarded Seacoast Science, Inc. a $541,648 Project Grant under the CDC Investigations and Technical Assistance program (CFDA 93.283) on September 30, 2025. The purpose of this award is to develop an auto-calibrating air quality monitoring system. Seacoast Science, Inc. is a for-profit company that specializes in advanced chemical sensors, detection devices, and monitoring systems, with a focus on innovative environmental and safety monitoring...
- The Centers for Disease Control and Prevention (CDC) awarded a $427,929 Cooperative Agreement under the CDC Investigations and Technical Assistance program (CFDA 93.283) to the Pennsylvania Department of Health (PADOH) to strengthen vaccine-preventable disease prevention and response. The award will fund the PADOH's immunization program, which includes the Bureau of Immunizations, to perform activities such as improving immunization information systems, enhancing field services, and supporting...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $501,200 Project Grant on Sep 30, 2025 to Aptus Biosciences LLC, a minority-owned small business located in Gainesville, Florida, under the CDC's "Prevention of Disease, Disability, and Death by Infectious Diseases" program (CFDA 93.084). The funding will support the development of a rapid, affordable, aptamer-based diagnostic test for Hepatitis C virus. Aptus Biosciences specializes in advanced diagnostic research and...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $7,994,888 Cooperative Agreement under the Allergy and Infectious Diseases Research (CFDA 93.855) program to Research Triangle Institute (RTI International) to establish and maintain the Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (REVAMPP) Coordinating and Data Sharing Center (CDSC). The CDSC will coordinate the REVAMPP network, comprised of 6-8 research centers, to...